Tissue-specific and paradoxical bile acid–FXR/TGR5 signaling in MASLD: reframing the brain–gut–liver axis
Year: 2026
Type: article
Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem disorder in which hepatic metabolic injury coexists with intestinal dysbiosis and neurobehavioral abnormalities. Bile acids function not only as digestive molecules but also as inter-organ signals through the nuclear receptor farnesoid X receptor (FXR) and the membrane receptor Takeda G protein-coupled receptor 5 (TGR5). This review reframes the bile acid–FXR/TGR5 pathway from a brain–gut–liver perspective, with particular emphasis on tissue-specific and sometimes paradoxical receptor functions. We summarize hepatic, intestinal, and central FXR/TGR5 signaling; discuss humoral and vagal routes linking the gut–liver axis with the brain; and critically examine conflicting findings arising from model selection, sex, bile acid profiling strategies, and global vs. tissue-specific receptor manipulation. We further reinterpret current therapeutic approaches, including FXR agonists, TGR5 agonists, GLP-1 receptor agonists, and natural products, in terms of tissue selectivity and central exposure. The available evidence supports a shift from indiscriminate receptor activation toward compartment-selective modulation, while also highlighting the need for prospective human studies, multi-tissue omics, and direct assessment of central bile acid signaling.
Source: Frontiers in Medicine
Institution: Gansu University of Traditional Chinese Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235228060
